National Guideline Clearinghouse | Systemic therapy for well and moderately differentiated unresectable pancreatic neuroendocrine tumours.

FULL-TEXT ►

National Guideline Clearinghouse | Systemic therapy for well and moderately differentiated unresectable pancreatic neuroendocrine tumours.



CancerControl Alberta

Guideline Title

Systemic therapy for well and moderately differentiated unresectable pancreatic neuroendocrine tumours.

Bibliographic Source(s)

Alberta Provincial Endocrine Tumour Team. Systemic therapy for well and moderately differentiated unresectable pancreatic neuroendocrine tumours. Version 2. Edmonton (AB): CancerControl Alberta; 2015 Feb. 18 p. (Clinical practice guideline; no. ENDO-001).  [68 references]

Guideline Status

This is the current release of the guideline.

This guideline updates a previous version: Alberta Provincial Endocrine Tumour Team. Targeted therapies for well and moderately differentiated unresectable pancreatic neuroendocrine tumours. Edmonton (Alberta): CancerControl Alberta; 2012 Nov. 16 p. (Clinical practice guideline; no. ENDO-001). [52 references]

This guideline meets NGC's 2013 (revised) inclusion criteria.